CME Group Inc.
CME
$276.29
$2.290.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.53B | 1.41B | 1.48B | 1.42B | 1.38B |
| Total Other Revenue | 107.60M | 108.80M | 106.60M | 105.20M | 101.30M |
| Total Revenue | 1.64B | 1.52B | 1.58B | 1.53B | 1.49B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.64B | 1.52B | 1.58B | 1.53B | 1.49B |
| SG&A Expenses | 407.30M | 417.00M | 426.80M | 402.70M | 399.50M |
| Depreciation & Amortization | 82.50M | 83.40M | 83.90M | 84.20M | 85.30M |
| Other Operating Expenses | 41.60M | 70.00M | 47.00M | 42.60M | 41.20M |
| Total Operating Expenses | 531.40M | 570.40M | 557.70M | 529.50M | 526.00M |
| Operating Income | 1.11B | 952.30M | 1.02B | 1.00B | 959.60M |
| Income Before Tax | 1.24B | 1.10B | 1.18B | 1.15B | 1.11B |
| Income Tax Expenses | 288.60M | 222.00M | 264.10M | 271.30M | 258.20M |
| Earnings from Continuing Operations | 956.20M | 874.60M | 912.80M | 883.20M | 855.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 956.20M | 874.60M | 912.80M | 883.20M | 855.20M |
| EBIT | 1.11B | 952.30M | 1.02B | 1.00B | 959.60M |
| EBITDA | 1.19B | 1.04B | 1.11B | 1.08B | 1.04B |
| EPS Basic | 2.63 | 2.40 | 2.51 | 2.43 | 2.35 |
| Normalized Basic EPS | 2.16 | 1.89 | 2.05 | 2.01 | 1.94 |
| EPS Diluted | 2.62 | 2.40 | 2.50 | 2.42 | 2.35 |
| Normalized Diluted EPS | 2.16 | 1.89 | 2.04 | 2.01 | 1.93 |
| Average Basic Shares Outstanding | 359.61M | 359.57M | 359.40M | 359.33M | 359.26M |
| Average Diluted Shares Outstanding | 360.23M | 360.05M | 359.99M | 359.87M | 359.83M |
| Dividend Per Share | 1.25 | 1.15 | 1.15 | 1.15 | 1.15 |
| Payout Ratio | 268.50% | 47.88% | 45.85% | 47.38% | 272.26% |